Pliant Therapeutics's total assets for Q3 2025 were $276.60M, a decrease of -7.75% from the previous quarter. PLRX total liabilities were $76.29M for the fiscal quarter, a -4.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.